Arbutus Biopharma Corp

NASDAQ:ABUS   3:59:53 PM EDT
2.24
+0.05 (+2.28%)
Other Pre-Announcement

Arbutus Reports First Quarter 2022 Financial Results

Published: 05/05/2022 11:48 GMT
Arbutus Biopharma Corp (ABUS) - Arbutus Reports First Quarter 2022 Financial Results and Provides Corporate Update.
Well Positioned Financially With a Projected Cash Runway Into Q2 of 2024.
Revenues Were $12.6 Million for Three Months Ended March 31, 2022 Compared to $2.1 Million for Same Period in 2021.
Qtrly Loss per Share of $0.11.
Expects a Net Cash Burn Between $90 to $95 Million in 2022.
Believes Its Cash Runway Will Be Sufficient to Fund Operations Into Q2 of 2024.
Q1 Earnings per Share View $-0.16, Revenue View $4.4 Million -- Refinitiv Ibes Data (analyst estimates).